KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Current Leases (2019 - 2025)

Cvs Health's Current Leases history spans 7 years, with the latest figure at $1.7 billion for Q4 2025.

  • For the quarter ending Q4 2025, Current Leases fell 0.8% year-over-year to $1.7 billion, compared with a TTM value of $1.7 billion through Dec 2025, down 0.8%, and an annual FY2025 reading of $1.7 billion, down 0.8% over the prior year.
  • Current Leases for Q4 2025 was $1.7 billion at Cvs Health, down from $1.9 billion in the prior quarter.
  • The five-year high for Current Leases was $1.9 billion in Q3 2024, with the low at $1.6 billion in Q4 2021.
  • Average Current Leases over 5 years is $1.8 billion, with a median of $1.8 billion recorded in 2021.
  • Year-over-year, Current Leases decreased 9.19% in 2023 and then grew 13.52% in 2024.
  • Tracing CVS's Current Leases over 5 years: stood at $1.6 billion in 2021, then grew by 1.94% to $1.7 billion in 2022, then rose by 3.75% to $1.7 billion in 2023, then rose by 0.57% to $1.8 billion in 2024, then fell by 0.8% to $1.7 billion in 2025.
  • Per Business Quant, the three most recent readings for CVS's Current Leases are $1.7 billion (Q4 2025), $1.9 billion (Q3 2025), and $1.9 billion (Q2 2025).